Kolexia
Quere Gilles
Pneumologie
Hôpital Morvan
Brest, France
78 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du poumon Carcinome pulmonaire à petites cellules Carcinome pulmonaire non à petites cellules Adénocarcinome Métastase tumorale Adénocarcinome pulmonaire Maladies auto-immunes Carcinome épidermoïde Maladies pulmonaires

Industries

A+A
9 collaboration(s)
Dernière en 2023
MSD
2 collaboration(s)
Dernière en 2022
AstraZeneca
2 collaboration(s)
Dernière en 2023
Takeda Pharmaceutical
1 collaboration(s)
Dernière en 2020

Dernières activités

Pembrolizumab plus pemetrexed-carboplatin combination in first-line treatment of advanced non-squamous non-small cell lung cancer: a multicenter real-life study (CAP29).
Translational lung cancer research   23 février 2023
Real-life second-line epirubicin-paclitaxel regimen as treatment of relapsed small-cell lung cancer: EpiTax study.
Cancer medicine   24 août 2022
Real-life experience of rare hepatoid adenocarcinomas of the lung: A large retrospective french cohort.
2022 ASCO Annual Meeting I   02 juin 2022
Toxicity after volumetric modulated arc therapy for lung cancer: a monocentric retrospective study.
Translational lung cancer research   20 avril 2022
71P Searching for predictive biomarkers of efficacy in small cell lung cancer (SCLC) patients treated with chemotherapy-immunotherapy combination using imaging mass cytometry (the HYPE study)
Abstract Book of the ESMO Congress 2021, 16 – 21 September 2021   01 septembre 2021
IMMUNO-PREDICT: Immunological Markers Predictive of Response and Toxicity to Checkpoint in Metastatic Non-Small-cell Lung Cancers
Essai Clinique (CHU Brest)   02 juin 2021
Vascular Acrosyndromes Associated With Prolonged Tumor Response in Advanced Lung Cancer Patients During Treatment With Antimetabolites: A Report of Two Cases.
Frontiers in oncology   01 avril 2021
Henoch-Schönlein Purpura Associated with Lung Cancer: When Paraneoplastic Manifestations Impede Oncological Management.
Case reports in immunology   06 février 2021
Thyroid dysfunction induced by immune checkpoint inhibitors is associated with a better progression-free survival and overall survival in non-small cell lung cancer: an original cohort study.
Cancer immunology, immunotherapy : CII   09 janvier 2021
Efficacy of Dabrafenib Plus Trametinib Combination in Patients with V600E-Mutant NSCLC in Real-World Setting: GFPC 01-2019.
Cancers   02 décembre 2020